Novel targets for the prevention of osteoporosis - lessons learned from studies of metabolic bone disorders.

about

Identification of biallelic LRRK1 mutations in osteosclerotic metaphyseal dysplasia and evidence for locus heterogeneity.

P2860

Q46231237-7C2BEBAB-47CE-4D7C-B370-C6235D102507

P2860

Novel targets for the prevention of osteoporosis - lessons learned from studies of metabolic bone disorders.

Item

http://www.wikidata.org/entity/Q38470745

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Novel targets for the preventi ...... s of metabolic bone disorders.

@en

type

Item

label

Novel targets for the preventi ...... s of metabolic bone disorders.

@en

prefLabel

Novel targets for the preventi ...... s of metabolic bone disorders.

@en

P1476

Novel targets for the preventi ...... s of metabolic bone disorders.

@en

P2093

Christian Schneider Thudium

http://www.w3.org/2001/XMLSchema#string

Claus Christiansen

http://www.w3.org/2001/XMLSchema#string

Kim Henriksen

http://www.w3.org/2001/XMLSchema#string

Morten Asser Karsdal

http://www.w3.org/2001/XMLSchema#string

P2860

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist

Targeted disruption of the Cl-/HCO3- exchanger Ae2 results in osteopetrosis in mice

Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II

Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus

Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man

High bone density due to a mutation in LDL-receptor-related protein 5

A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

P304

1575-1584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2015.1045415

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25960169

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

Novel targets for the prevention of osteoporosis - lessons learned from studies of metabolic bone disorders.

about

P2860

P2860

Novel targets for the prevention of osteoporosis - lessons learned from studies of metabolic bone disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921